MedWire News -- The presence of anti-platelet factor 4/heparin (PF4/H) antibodies of any immunoglobulin class before cardiac surgery is not associated with an increased risk for heparin-induced thrombocytopenia (HIT), say researchers.
MedWire News -- The presence of anti-platelet factor 4/heparin (PF4/H) antibodies of any immunoglobulin class before cardiac surgery is not associated with an increased risk for heparin-induced thrombocytopenia (HIT), say researchers.